Clinical Trial Details

Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Complete Title: AGCT1531, Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Trial Phase: III
Investigator: Tyler Ketterl

This partially randomized phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Keywords:
  • Pediatric Cancers, Miscellaneous; Ovarian Cancer; Carcinoma, Embryonal; Choriocarcinoma; Endodermal Sinus Tumor; Mesonephroma; Pregnancy Complications, Neoplastic; Pregnancy Complications; Genital Neoplasms, Female; Carcinoma; Endocrine Gland Neoplasms; Adnexal Diseases; Trophoblastic Neoplasms; Gonadal Disorders; Solid Tumors; Teratomas; Neoplasms, Germ Cell and Embryonal; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial; Adenocarcinoma
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.